Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Ovarian Cancer.

Suprema's Biostar 2 program was accessed online by cyber-security researchers earlier this month. The researchers say they found data from companies that use the system. Suprema said the access ...

The new Suprema BioStar 2.1 includes number of software and hardware that further improves usability and expandability of the platform. The release includes BioStar 2 API, BioStar 2 Device SDK, and ...

BioStar is the name of Suprema's next generation access control system based on IP connectivity and biometric security. Server-client based (32 clients accessible). Network interface: TCP/IP, RS485.

This collaboration strengthens the commitment of both companies to advance clinical research, leveraging Novotech’s expertise and technical platforms to support Biostar’s clinical development ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...